Decrease in pupillary constriction amplitude with repetitive stimulation in AD patients correlated with lower Aβ42 protein levels (p = 0.01) and a trend with higher tau levels in CSF (p = 0.08) (78). The gene discussed is MAPT; the disease is Alzheimer disease.